AMETEK Shares Climb Following Earnings Beat and Guidance Boost
AMETEK shares rose to $238.24 after the company surpassed third-quarter forecasts and increased its 2026 outlook, while institutional ownership and valuations draw scrutiny.
Shares of AMETEK, Inc. climbed 4.2% to $238.24 on November 09, 2026. The move followed a strong quarterly financial report and an upgraded annual outlook. The stock has traded between a 52-week low of $188.47 and a 52-week high of $261.16, gaining 16.6% year-to-date and 22.1% over the past year.
On November 3rd, the manufacturer posted third-quarter earnings of $2.21 per share, beating consensus expectations of $2.11 per share and improving from $1.89 per share a year earlier. Revenue climbed 17.3% year over year to reach $2.22 billion, exceeding projections of $2.12 billion. Following record third-quarter sales, the company reportedly raised its 2026 outlook. For the full fiscal year, sell-side analysts project AMETEK will post earnings of 8.59 per share.
Alongside quarterly results, the company declared a regular quarterly dividend of $0.34 per share, payable on Friday, December 18th to shareholders of record on Friday, December 4th. This equates to an annualized payout of $1.36 per share, representing a 0.6% dividend yield and a dividend payout ratio of 19.18%.
Analyst coverage remains broadly favorable, with MarketBeat reporting an average consensus rating of "Moderate Buy" across 19 covering brokerages and an average price target of $278.06. Truist Financial set a $316.00 target, while Deutsche Bank Aktiengesellschaft holds a $318.00 target. Citigroup recently forecast strong share appreciation. However, Mizuho trimmed its price target from $285.00 to $275.00, keeping an "outperform" rating, amid reports that shares briefly fell below their 200-day moving average.
Despite positive business results, valuation metrics and insider trades indicate some caution. GuruFocus noted that the share price of $238.24 stands 5.9% above its GF Value estimate of $224.95, while the stock carries a GF Score of 98/100. Over the past 12 months, insiders bought $1.0M and sold $29.5M, leaving net sales of $28.5M. Meanwhile, institutional investors hold 87.43% of the stock, with third-quarter filings showing StoneX Group Inc., Kornitzer Capital Management Inc., and Boston Trust Walden Corp trimming their positions.